SOLICITATION NOTICE
66 -- BD LSRFortessa X-20
- Notice Date
- 7/24/2013
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bldg 1050, Frederick, Maryland, 21702, United States
- ZIP Code
- 21702
- Solicitation Number
- NCI-130086-TK
- Archive Date
- 8/23/2013
- Point of Contact
- Tiffany D. Kittrell, Phone: 2402765434
- E-Mail Address
-
Tiffany.kittrell@nih.gov
(Tiffany.kittrell@nih.gov)
- Small Business Set-Aside
- N/A
- Description
- Title: BD LSRFortessa X-20 Document Type: Pre-solicitation notice Solicitation Number: NCI-130086-TK Proposed Posted Date: July 24, 2013 Proposed Response Date: August 8, 2013 11AM EST Classification Code: 66 – Instruments & Laboratory Equipment NAICS Code: 334516 Small Business Size Standard: 500 Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room1E140, Bethesda, MD 20892 USA Description: The National Cancer Institute (NCI), Center for Cancer Research/Experimental Immunology Branch (EIB) plans to procure on a sole source bases with Becton, Dickinson and Company at 2350 Quime Drive San Jose, CA 95131 for a BD LSRFortessa X-20. The products herein are being procured in accordance with the simplified acquisition procedures as authorized by FAR Part 13.106-1 (b) (2) and FAR 13.501 (a)(1)(ii).The North American Industry Classification System Code is 334516 and the business size standard in 500. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. It has been determined that there is no opportunity to acquire green products or services under this procurement. Delivery shall be made within 4 weeks of contract award. The Experimental Immunology Branch (EIB) Flow Cytometry Facility provides basic research support to members of the EIB as well as to investigators throughout CCR, NCI. Support is provided using 7 instruments manufactured by Becton, Dickinson & Co. Each instrument supports multiple complex and varied experiments each day, and each instrument is fully utilized. The EIB facility is required to maintain equipment that provides for a wide range of applications and that includes the ability to modify and adapt capabilities as new applications are developed. In general, this requirement is satisfied by utilizing instrumentation with a wide range of laser excitation wavelengths and power outputs combined with the ability to custom configure fluorescence detector capabilities. The facility currently operates two (2) 5-laser BD Biosciences LSR Flow Cytometer Analyzers that have proven to be uniquely suited to the analytical requirements or our user base. This is because the instrument not only provides 5 separate lasers and 18 color detector capabilities; these instruments are particularly suited to operation by users with minimal facility supervision. The purpose of this acquisition is to acquire a third LSRFortessa Flow Cytometer Analyzer. Critically, the new instrument required must provide seamless continuity with the existing instruments such that data produced on the new instrument will be identical to that from the existing instruments. Salient Characteristics: - Must have the capability of being utilized by multiple users for a variety of applications in immunobiology and molecular immunology. - Must have the ability to customize and configure fluorescence detector capabilities, including user access to, and ability to change, fluorescence bandpass and long pass filters - Must have ten (10) color simultaneous detection plus FSC and SSC from three (3) lasers as delivered. - Must be upgradable to the following optional laser wavelengths and powers: 532nm 150mw, 552nm 150mw, 445nm 75mw, 514nm 20mw, 561nm 150mw, 592nm 200mw, 637nm 140mw. 685nm 40mw, 730nm 30mw, 750nm 20mw, 785nm 50mw. - Must have the demonstrated capability for onsite OEM upgrade to simultaneous eighteen (18) color detection from five (5) lasers. - Must have the ability to incorporate five (5) spatially separated lasers to be used simultaneously and with automatic time delay calculation using instrument set-up software. - Must have variable detector configurations using reflected light trigon and/or polygon PMT arrays. - Must have the capability to detect less than 30 MESF (mean equivalent soluble fluorescence) particles on PE (phycoerythrin) channel and 10 MESF on Pe-Cy7 (tandem of phycoerythrin and cyanine dye 7) channel. - Must have the capability of resolving 0.5um beads from noise on Side Scatter Channel. - Optical design must be able to deliver greater than 80% of stated laser power at the flow cell. - Must be able to have a Fluorescence Linearity Doublet Singlet Ratio of 1.95-2.05 for CEN (chicken erythrocyte nuclei) stained with PI (propidium iodide). - Must incorporate all digital electronics to provide data acquisition rates up to 40,000 events per second with beads and10, 000 events per second with cells. - Must incorporate manual (not motor driven) sample change capability, and provide for sample carryover of less than 0.1% within 5 seconds. - Must have integrated laser power control software that provides for turning power on/off and adjustable power level control for each installed laser independently. - Must have three (3) lasers with the following wavelength (nm) and power output maximum(milliwatts): a. 405 nm, 100 milliwatts b. 488 nm, 50 milliwatts c. 640 nm, 100 milliwatts - Must be upgradable to fully integrated automatic sample injection from micro titer plates (96 or 384 well) with operation controlled by the cytometer software. - Must incorporate full 1 year parts and labor warranty from date of installation acceptance that includes on-site service by OEM trained engineers using OEM approved parts and that provides 48 hour on site response time. Becton Dickinson is the only known manufacturer of a multi-laser flow cytometer analyzer system with the above salient characteristics. This is not a solicitation for competitive quotations. However, if any interested party, especially a small business, believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on August 8, 2013. Electronic capability statements will be accepted (i.e. email or fax). An original and one copy must be sent to the NCI Office of Acquisitions at the address stated above. All questions must be in writing and can be faxed to (240) -276-5401 or emailed to Tiffany Kittrell, Contract Specialist at Tiffany.kittrell@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the System for Award Management (SAM) www.sam.gov. No collect calls will be accepted. Please reference solicitation number NCI-­­­­­130086-TK on all correspondence.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/FCRF/NCI-130086-TK/listing.html)
- Record
- SN03125793-W 20130726/130724235344-f62263d34a27092b3a25fc6e128a2d30 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |